Charles River Laboratories | CRL - 贷款资金

股票价格
156.03
每天变化
3.60 2.36%
每月一次
-14.78%
每年
15.59%
Q2 预测
147.82


金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 7.8B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


贷款资金 更改 日
Agilent USD 3.05B 0 2025-12
Align Technology USD 0 0 2024-12
Bio-Rad Laboratories USD 802.9M 398.8M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Cardinal Health USD 8.25B 102M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Cigna USD 29.37B 1.5B 2026-03
Concord Medical Services Hldg CNY 2.27B 3.79M 2025-06
CVS Health USD 60.53B 29M 2026-03
Danaher USD 17.56B 855M 2026-03
Dentsply International USD 2.01B 9M 2026-03
Elevance Health USD 30.77B 29M 2026-03
Humana USD 12.27B 95M 2026-03
Illumina USD 1.49B 0 2026-03
Incyte USD 29.41M 785K 2026-03
Intrexon USD 0 198.67M 2024-06
IQVIA Holdings USD 13.99B 105M 2026-03
Laboratory Of America USD 5.9B 748.3M 2026-03
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Lonza CHF 3.88B 323M 2025-12
McKesson USD 5.26B 166M 2026-03
Merck EUR 10.8B 72M 2026-03
Mettler Toledo International USD 2.16B 73.35M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Quest Diagnostics USD 5.16B 12M 2026-03
Revvity USD 2.63B 836K 2026-03
Thermo Fisher Scientific USD 40.07B 4.22B 2026-03
United Therapeutics USD 100M 100M 2024-06
UnitedHealth USD 71.44B 880M 2026-03
Veradigm USD 200.4M 69K 2022-12
Waters USD 5.22B 3.81B 2026-03
West Pharmaceutical Services USD 202.8M 0 2026-03